Rockville-based EntreMed cuts loss in first quarter

EntreMed Inc., of Rockville, a clinical-stage pharmaceutical company developing drugs for the treatment of cancer, reduced its net loss in the 2013 first-quarter, reporting a loss of $1.1 million, or 5 cents per diluted share versus a net loss of $2.5 million, or 23 cents per diluted share, for the same period last year.

Leave a Reply

Your email address will not be published. Required fields are marked *